Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

Clinical trial NCT06641089 · RECRUITING

Trial details

NCT number: NCT06641089
Sponsor: MoonLake Immunotherapeutics AG
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Arthritis, Psoriatic

Start date: 2024-10-15
Primary completion: 2027-01-15
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.